Reproduction of Prior Art
Controlled execution and characterization of prior-art examples where the resulting material matters.
Support Paragraph IV and ANDA matters with solid-state and analytical evidence
Paragraph IV and ANDA matters can depend on highly specific technical questions: whether a proposed product contains a claimed form, whether a method distinguishes relevant forms, whether a prior-art procedure is enabling in practice, whether a formulation or impurity profile matters, or whether a comparison has been made under scientifically appropriate conditions.
Triclinic supports these matters by designing and executing analytical work around the technical issue, then organizing data for counsel, CMC teams, formulation scientists, and experts.
The goal is disciplined scientific evidence. Triclinic does not provide legal conclusions about infringement, validity, or approval strategy.
When this page is the right starting point
- A legal or technical team needs scientific evidence tied to Paragraph IV, ANDA, Hatch-Waxman, 505(b)(2), or related patent questions.
- The asserted issue involves solid form, formulation composition, analytical specificity, impurity identity, particle properties, or material performance.
- A prior-art example, patent example, accused product, proposed generic product, or retained sample must be characterized or compared.
- Expert analysis requires data that can be traced from sample receipt through method execution and interpretation.
- Counsel needs technical support that separates scientific conclusions from legal conclusions.
How Triclinic approaches Paragraph IV ANDA expert support
The work starts by defining the legal or technical question under counsel or client direction. Triclinic then maps that question to measurable properties and selects methods that can answer it with appropriate specificity.
For solid-state disputes, a defensible answer often requires a combination of XRPD, thermal analysis, spectroscopy, microscopy, moisture analysis, chromatography, structure determination, or other methods. The point is not to generate more data; it is to generate the right data for the claim or factual dispute.
Reporting is organized so that raw observations, method limits, assumptions, comparisons, and scientific interpretations are clear to counsel and experts.
- Define the patent claim, product attribute, prior-art procedure, or technical assertion being tested.
- Identify the samples, controls, lots, product materials, and comparison materials needed for the work.
- Use orthogonal methods where a single test cannot separate form, chemistry, hydration, excipient interference, or processing effects.
- Maintain records that support later review of sample handling, testing conditions, calculations, and interpretation.
- Prepare data tables, figures, technical narratives, and expert-support materials as appropriate to the matter.
Technical issues commonly addressed
ANDA and Paragraph IV matters can involve chemistry, materials science, and analytical-method questions that must be answered before legal conclusions can be responsibly framed.
Triclinic can help determine what a material is, whether it matches or differs from another material, whether a procedure produces a relevant form, and whether an analytical method is specific enough for the dispute.
- Polymorph, salt, cocrystal, hydrate, solvate, amorphous, and mixture characterization.
- Reproduction of patent or prior-art examples followed by analytical characterization.
- Comparative testing of branded, generic, development, retained, or litigation samples.
- Assessment of analytical specificity and method limitations.
- Impurity, contaminant, excipient, particle, or morphology questions that affect the technical position.
Timing, exclusivity, and evidence planning
Paragraph IV and ANDA strategy is timing-sensitive. FDA describes a Paragraph IV certification as a generic applicant’s position that an Orange Book listed patent is invalid, unenforceable, or not infringed, and a timely infringement suit generally postpones FDA approval for 30 months unless the matter is resolved earlier. DrugPatentWatch similarly treats patent-expiration data, NCE-1 timing, and Paragraph IV challenges as lifecycle-intelligence inputs.
That timing changes how technical work should be scoped. Comparative testing, prior-art reproduction, method-specificity assessment, and sample sourcing should be planned early enough for counsel and experts to use the data before reports, declarations, claim charts, settlement positions, or hearing materials become locked.
Review DrugPatentWatch’s overview of pharmaceutical patent longevity · Review FDA’s Paragraph IV patent certification overview
Typical deliverables
- Paragraph IV or ANDA technical work plan.
- Claim-focused or question-focused analytical strategy.
- Sample comparison matrix and testing rationale.
- Raw data, processed data, figures, and interpretive summaries.
- Technical memorandum, declaration support, expert-report support, or recommendations for additional experiments.
- Clear separation of scientific observations, assumptions, limitations, and interpretations.
Related services and capabilities
Solid-State Patent Strength Assessment
Assessment of whether solid-form claims are supported by reproducible, distinguishable analytical evidence.
Testifying and Fact Experts
Fact and expert-science support for chemistry, materials, and solid-state disputes.
Solid Form Development
Screening, selection, characterization, and control of polymorphs, salts, cocrystals, hydrates, solvates, and amorphous materials.
Structure Elucidation
Crystal, molecular, impurity, and structure-determination support when structural proof is central to the question.
Common questions
Common questionsCan Triclinic support counsel in Paragraph IV matters?
Yes. Triclinic can support counsel and experts with experimental design, data review, characterization, prior-art reproduction, product comparison, and technical interpretation. Counsel controls legal strategy and conclusions.
Can Triclinic compare a generic product to a patent claim?
Triclinic can perform scientific testing and comparisons tied to claim elements or technical assertions. Whether the resulting data establish a legal position is a question for counsel.
Can prior art or patent examples be reproduced?
Yes, where the procedure, materials, assumptions, and reasonable experimental variables can be defined. Ambiguities and deviations should be documented because they may affect what material is produced.
Which techniques may be used?
Technique selection depends on the dispute. XRPD, DSC, TGA, Raman, FTIR, NMR, chromatography, LC/MS, microscopy, DVS, Karl Fischer, SCXRD, MicroED, and chemical imaging may be used alone or in combination.
Does Triclinic provide infringement or validity opinions?
No. Triclinic provides scientific data, testing, and technical interpretation. Infringement, validity, and litigation strategy are legal conclusions for counsel and retained legal experts.
What should be preserved for litigation-quality testing?
Preserve sample provenance, custody, lot identity, storage, preparation, instrument configuration, raw data, processing parameters, deviations, reference materials, replicate strategy, and contemporaneous observations so the work can be independently reviewed.
Discuss ANDA support
Share the claim, technical issue, product or material type, available samples, known analytical data, desired decision point, and litigation or filing timeline so Triclinic can scope the scientific work around the actual dispute.
